Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-small Cell Lung Cancer

NSCLC patients are characterized by increased IL-33 and caspase-3 serum levels. These findings suggest that these markers could serve as valuable diagnostic and prognostic indicators, in addition to being potential therapeutic targets.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2025-10-29
DOI
https://doi.org/10.21873/invivo.14127
Primary Topic
IL-33, ST2, and ILC Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-small Cell Lung Cancer

Orçun Avşar, Zerrin Barut, Sibel Arınç, Fatma Tuba Akdeniz et al.
In Vivo
IL-33, ST2, and ILC Pathways
article

Simultaneous Investigation of sST2, IL-33, and Caspase-3 Serum Levels in Non-small Cell Lung Cancer

Orçun Avşar, Zerrin Barut, Sibel Arınç, Fatma Tuba Akdeniz, Turgay İşbir
article en

Abstract

NSCLC patients are characterized by increased IL-33 and caspase-3 serum levels. These findings suggest that these markers could serve as valuable diagnostic and prognostic indicators, in addition to being potential therapeutic targets.

In VivoVol. 39(6)
Yeditepe University (TR), Hitit Üniversitesi (TR), Chest Diseases Hospital (KW), Antalya Bilim University (TR), Yedikule Teaching Hospital (TR), Okan University (TR)
Openalex Percentile: Top 67%
IL-33, ST2, and ILC Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.